NASDAQ: CITECartica Acquisition Corp Stock
$11.15-0.05 (-0.45%)
Updated Apr 26, 2024
CITE Price
$11.15
Fair Value Price
N/A
Market Cap
$111.10M
52 Week Low
$10.34
52 Week High
$12.67
P/E
34.84x
P/B
-65.19x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$6.38M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.06
Operating Cash Flow
-$1M
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CITE Overview
Cartica Acquisition Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, stock purchases, recapitalizations, reorganizations, or related business combinations. It targets the technology sector in India. Cartica Acquisition was incorporated in 2021 and is based in Washington, DC.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CITE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CITE was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CITE is good value based on its earnings relative to its share price (34.84x), compared to the US market average (41.14x)
P/E vs Market Valuation
CITE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more CITE due diligence checks available for Premium users.
Be the first to know about important CITE news, forecast changes, insider trades & much more!
CITE News
Valuation
CITE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
34.84x
Industry
31.79x
Market
41.14x
CITE is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CITE is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CITE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-65.19x
Industry
-14.35x
CITE's financial health
Profit margin
Revenue
$0.0
Net Income
$527.5k
Profit Margin
0%
CITE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$46.4M
Liabilities
$1.8M
Debt to equity
-1.06
CITE's short-term liabilities ($820.77k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CITE's long-term liabilities ($981.00k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CITE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CITE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$163.3k
Investing
$0.0
Financing
$150.0k
CITE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CITE vs Shell Company Stocks
Cartica Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.